
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $17.7B | $16.3B | $14.4B | $13.7B | $12.9B | |
Revenue Growth (YoY) | -9.44% | -8.26% | -11.28% | -5.29% | -5.82% | |
Cost of Revenues | $14.1B | $12.7B | $11.2B | $10.6B | $9.8B | |
Gross Profit | $3.6B | $3.6B | $3.2B | $3.1B | $3.1B | |
Gross Profit Margin | 20.55% | 22.02% | 22.07% | 22.62% | 24.09% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.1B | $724M | $2.8B | $1.7B | $1.1B | |
Other Inc / (Exp) | $1.3B | $139M | $321M | $195M | -$2M | |
Operating Expenses | $4B | $2.4B | $4.3B | $3.1B | $2.4B | |
Operating Income | -$393M | $1.1B | -$1.1B | -$2M | $698M | |
Net Interest Expenses | $263M | $139M | $65M | $84M | $66M | |
EBT. Incl. Unusual Items | $654M | $1.1B | -$885M | $109M | $630M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $800M | $405M | -$319M | $23M | $234M | |
Net Income to Company | -$146M | $736M | -$566M | $86M | $396M | |
Minority Interest in Earnings | -$3M | -$18M | -$2M | $5M | -$7M | |
Net Income to Common Excl Extra Items | -$149M | $718M | -$568M | $91M | $389M | |
Basic EPS (Cont. Ops) | -$0.59 | $2.87 | -$2.48 | $0.46 | $2.15 | |
Diluted EPS (Cont. Ops) | -$0.59 | $2.81 | -$2.48 | $0.46 | $2.10 | |
Weighted Average Basic Share | $254.1M | $250M | $229M | $195.8M | $180.7M | |
Weighted Average Diluted Share | $254.1M | $255.2M | $229M | $198.8M | $184.9M | |
EBITDA | $3B | $3.1B | $866M | $1.8B | $2.2B | |
EBIT | $1B | $1.3B | -$685M | $407M | $895M | |
Revenue (Reported) | $17.7B | $16.3B | $14.4B | $13.7B | $12.9B | |
Operating Income (Reported) | -$393M | $1.1B | -$1.1B | -$2M | $698M | |
Operating Income (Adjusted) | $1B | $1.3B | -$685M | $407M | $895M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $4.4B | $4B | $3.6B | $3.4B | $3.2B | |
Revenue Growth (YoY) | -8.93% | -8.6% | -10.4% | -5.71% | -6.41% | |
Cost of Revenues | $3.6B | $3.2B | $2.7B | $2.6B | $2.4B | |
Gross Profit | $824M | $847M | $849M | $798M | $768M | |
Gross Profit Margin | 18.79% | 21.13% | 23.64% | 23.57% | 24.24% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $471M | -$369M | $1.8B | $740M | $127M | |
Other Inc / (Exp) | -$613M | $35M | $198M | $2M | $21M | |
Operating Expenses | $949M | $54M | $2.2B | $1.1B | $439M | |
Operating Income | -$125M | $793M | -$1.3B | -$291M | $329M | |
Net Interest Expenses | $55M | $29M | $17M | $20M | $12M | |
EBT. Incl. Unusual Items | -$793M | $799M | -$1.2B | -$309M | $338M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $11M | $260M | -$405M | -$114M | $75M | |
Net Income to Company | -$804M | $539M | -$758M | -$195M | $263M | |
Minority Interest in Earnings | $6M | -$9M | $2M | -$5M | $1M | |
Net Income to Common Excl Extra Items | -$798M | $530M | -$756M | -$200M | $264M | |
Basic EPS (Cont. Ops) | -$3.14 | $2.18 | -$3.38 | -$1.10 | $1.46 | |
Diluted EPS (Cont. Ops) | -$3.14 | $2.14 | -$3.38 | -$1.10 | $1.43 | |
Weighted Average Basic Share | $254.5M | $242.8M | $224M | $181.2M | $181.1M | |
Weighted Average Diluted Share | $254.5M | $248.1M | $224M | $184.5M | $185.7M | |
EBITDA | -$234M | $1.3B | -$718M | $124M | $714M | |
EBIT | -$716M | $842M | -$1.1B | -$233M | $396M | |
Revenue (Reported) | $4.4B | $4B | $3.6B | $3.4B | $3.2B | |
Operating Income (Reported) | -$125M | $793M | -$1.3B | -$291M | $329M | |
Operating Income (Adjusted) | -$716M | $842M | -$1.1B | -$233M | $396M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $17.7B | $16.3B | $14.4B | $13.7B | $12.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $14.1B | $12.7B | $11.2B | $10.6B | $9.8B | |
Gross Profit | $3.6B | $3.6B | $3.2B | $3.1B | $3.1B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.1B | $724M | $2.8B | $1.7B | $1.1B | |
Other Inc / (Exp) | $1.3B | $139M | $321M | $195M | -$2M | |
Operating Expenses | $4B | $2.4B | $4.3B | $3.1B | $2.4B | |
Operating Income | -$393M | $1.1B | -$1.1B | -$2M | $698M | |
Net Interest Expenses | $263M | $139M | $65M | $84M | $66M | |
EBT. Incl. Unusual Items | $654M | $1.1B | -$885M | $109M | $630M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $800M | $405M | -$319M | $23M | $234M | |
Net Income to Company | -$146M | $736M | -$566M | $86M | $396M | |
Minority Interest in Earnings | -$3M | -$18M | -$2M | $5M | -$7M | |
Net Income to Common Excl Extra Items | -$149M | $718M | -$568M | $91M | $389M | |
Basic EPS (Cont. Ops) | -$0.59 | $2.92 | -$2.56 | $0.38 | $2.14 | |
Diluted EPS (Cont. Ops) | -$0.62 | $2.85 | -$2.58 | $0.37 | $2.11 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $3B | $3.1B | $866M | $1.8B | $2.2B | |
EBIT | $1B | $1.3B | -$685M | $407M | $895M | |
Revenue (Reported) | $17.7B | $16.3B | $14.4B | $13.7B | $12.9B | |
Operating Income (Reported) | -$393M | $1.1B | -$1.1B | -$2M | $698M | |
Operating Income (Adjusted) | $1B | $1.3B | -$685M | $407M | $895M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $16.3B | $14.4B | $13.7B | $12.9B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $12.7B | $11.2B | $10.6B | $9.8B | -- | |
Gross Profit | $3.6B | $3.2B | $3.1B | $3.1B | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $724M | $2.8B | $1.7B | $1.1B | -- | |
Other Inc / (Exp) | $139M | $321M | $195M | -$2M | -- | |
Operating Expenses | $2.4B | $4.3B | $3.1B | $2.4B | -- | |
Operating Income | $1.1B | -$1.1B | -$2M | $698M | -- | |
Net Interest Expenses | $139M | $65M | $84M | $66M | -- | |
EBT. Incl. Unusual Items | $1.1B | -$885M | $109M | $630M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $405M | -$319M | $23M | $234M | -- | |
Net Income to Company | $736M | -$566M | $86M | $396M | -- | |
Minority Interest in Earnings | -$18M | -$2M | $5M | -$7M | -- | |
Net Income to Common Excl Extra Items | $718M | -$568M | $91M | $389M | -- | |
Basic EPS (Cont. Ops) | $2.92 | -$2.56 | $0.38 | $2.14 | -- | |
Diluted EPS (Cont. Ops) | $2.85 | -$2.58 | $0.37 | $2.11 | -- | |
Weighted Average Basic Share | $1B | $916M | $783.3M | $722.7M | -- | |
Weighted Average Diluted Share | $1B | $927.6M | $793.2M | $737.3M | -- | |
EBITDA | $3.1B | $866M | $1.8B | $2.2B | -- | |
EBIT | $1.3B | -$685M | $407M | $895M | -- | |
Revenue (Reported) | $16.3B | $14.4B | $13.7B | $12.9B | -- | |
Operating Income (Reported) | $1.1B | -$1.1B | -$2M | $698M | -- | |
Operating Income (Adjusted) | $1.3B | -$685M | $407M | $895M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $2B | $1.8B | $1.5B | $1.4B | $1.3B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $567M | $617M | $565M | $512M | $477M | |
Other Current Assets | $357M | $268M | $255M | $146M | $118M | |
Total Current Assets | $8.2B | $7.4B | $6.1B | $5.1B | $5.4B | |
Property Plant And Equipment | $4.3B | $3.5B | $2.9B | $2.4B | $1.9B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $641M | $617M | $539M | $532M | $526M | |
Other Intangibles | $4B | $3.4B | $2.6B | $2.1B | $1.6B | |
Other Long-Term Assets | $4.5B | $4.9B | $3.3B | $2.9B | $3B | |
Total Assets | $22B | $20.1B | $15.8B | $13.9B | $13.2B | |
Accounts Payable | $914M | $840M | $782M | $846M | $549M | |
Accrued Expenses | $4.1B | $3.5B | $2.4B | $2B | $1.9B | |
Current Portion Of Long-Term Debt | $556M | $249M | $176M | $93M | $757M | |
Current Portion Of Capital Lease Obligations | $816M | $677M | $532M | $460M | $350M | |
Other Current Liabilities | $118M | $23M | $9M | -- | -- | |
Total Current Liabilities | $8.2B | $6.9B | $5.2B | $4.4B | $4.4B | |
Long-Term Debt | $3.8B | $4.6B | $3.6B | $3.6B | $2.8B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $16.7B | $14.8B | $12B | $10.8B | $9.7B | |
Common Stock | $3M | $3M | $2M | $2M | $2M | |
Other Common Equity Adj | -$302M | -$385M | -$774M | -$732M | -$762M | |
Common Equity | $5B | $5.1B | $3.5B | $2.8B | $3.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $335M | $323M | $323M | $255M | $261M | |
Total Equity | $5.3B | $5.4B | $3.8B | $3.1B | $3.5B | |
Total Liabilities and Equity | $22B | $20.1B | $15.8B | $13.9B | $13.2B | |
Cash and Short Terms | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
Total Debt | $4.6B | $5.2B | $3.9B | $3.7B | $3.6B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $2B | $1.8B | $1.5B | $1.4B | $1.3B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $567M | $617M | $565M | $512M | $477M | |
Other Current Assets | $357M | $268M | $255M | $146M | $118M | |
Total Current Assets | $8.2B | $7.4B | $6.1B | $5.1B | $5.4B | |
Property Plant And Equipment | $4.3B | $3.5B | $2.9B | $2.4B | $1.9B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $641M | $617M | $539M | $532M | $526M | |
Other Intangibles | $4B | $3.4B | $2.6B | $2.1B | $1.6B | |
Other Long-Term Assets | $4.5B | $4.9B | $3.3B | $2.9B | $3B | |
Total Assets | $22B | $20.1B | $15.8B | $13.9B | $13.2B | |
Accounts Payable | $914M | $840M | $782M | $846M | $549M | |
Accrued Expenses | $4.1B | $3.5B | $2.4B | $2B | $1.9B | |
Current Portion Of Long-Term Debt | $556M | $249M | $176M | $93M | $757M | |
Current Portion Of Capital Lease Obligations | $816M | $677M | $532M | $460M | $350M | |
Other Current Liabilities | $118M | $23M | $9M | -- | -- | |
Total Current Liabilities | $8.2B | $6.9B | $5.2B | $4.4B | $4.4B | |
Long-Term Debt | $3.8B | $4.6B | $3.6B | $3.6B | $2.8B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $16.7B | $14.8B | $12B | $10.8B | $9.7B | |
Common Stock | $3M | $3M | $2M | $2M | $2M | |
Other Common Equity Adj | -$302M | -$385M | -$774M | -$732M | -$762M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $335M | $323M | $323M | $255M | $261M | |
Total Equity | $5.3B | $5.4B | $3.8B | $3.1B | $3.5B | |
Total Liabilities and Equity | $22B | $20.1B | $15.8B | $13.9B | $13.2B | |
Cash and Short Terms | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
Total Debt | $4.6B | $5.2B | $3.9B | $3.7B | $3.6B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$146M | $736M | -$566M | $86M | $396M | |
Depreciation & Amoritzation | $2B | $1.7B | $1.6B | $1.4B | $1.3B | |
Stock-Based Compensation | $56M | $101M | $108M | $109M | $79M | |
Change in Accounts Receivable | $257M | $228M | $412M | $176M | $320M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $124M | $1.5B | $1.4B | $1.4B | $1.4B | |
Capital Expenditures | $515M | $549M | $455M | $407M | $576M | |
Cash Acquisitions | $5.1B | $533M | -$147M | $26M | $26M | |
Cash From Investing | $4.7B | -$60M | -$635M | -$491M | -$512M | |
Dividends Paid (Ex Special Dividend) | -$53M | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $5B | $4B | $1.5B | $1.8B | $367M | |
Long-Term Debt Repaid | -$10.3B | -$4.8B | -$2.3B | -$2.3B | -$667M | |
Repurchase of Common Stock | -- | -$628M | -$669M | -$898M | -$14M | |
Other Financing Activities | -$69M | -$441M | -$23M | -$56M | -$3M | |
Cash From Financing | -$5.5B | -$1.8B | -$1.5B | -$1.5B | -$317M | |
Beginning Cash (CF) | $3.7B | $3B | $2.7B | $1.9B | $1.2B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$687M | -$377M | -$727M | -$617M | $569M | |
Ending Cash (CF) | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
Levered Free Cash Flow | -$391M | $952M | $960M | $954M | $822M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $282M | $103M | $42M | $25M | -- | |
Depreciation & Amoritzation | $427M | $398M | $351M | $333M | -- | |
Stock-Based Compensation | $25M | $28M | $23M | $23M | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$29M | $163M | $127M | $238M | -- | |
Capital Expenditures | $220M | $118M | $140M | $155M | -- | |
Cash Acquisitions | $513M | -$36M | -$7M | -- | -- | |
Cash From Investing | $311M | -$192M | -$199M | -$188M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $235M | $292M | $546M | $323M | -- | |
Long-Term Debt Repaid | -$1B | -$398M | -$436M | -$263M | -- | |
Repurchase of Common Stock | -$48M | -$272M | -$285M | -$2M | -- | |
Other Financing Activities | -$22M | -$17M | -$35M | -$17M | -- | |
Cash From Financing | -$866M | -$394M | -$210M | $41M | -- | |
Beginning Cash (CF) | $3B | $2.7B | $1.9B | $1.2B | -- | |
Foreign Exchange Rate Adjustment | $13M | -$50M | -- | $2M | -- | |
Additions / Reductions | -$584M | -$423M | -$282M | $91M | -- | |
Ending Cash (CF) | $2.5B | $2.2B | $1.6B | $1.3B | -- | |
Levered Free Cash Flow | -$249M | $45M | -$13M | $83M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$146M | $736M | -$566M | $86M | $396M | |
Depreciation & Amoritzation | $2B | $1.7B | $1.6B | $1.4B | $1.3B | |
Stock-Based Compensation | $56M | $101M | $108M | $109M | $79M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $124M | $1.5B | $1.4B | $1.4B | $1.4B | |
Capital Expenditures | $515M | $549M | $455M | $407M | $576M | |
Cash Acquisitions | $5.1B | $533M | -$147M | $26M | $26M | |
Cash From Investing | $4.7B | -$60M | -$635M | -$491M | -$512M | |
Dividends Paid (Ex Special Dividend) | -$53M | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $5B | $4B | $1.5B | $1.8B | $367M | |
Long-Term Debt Repaid | -$10.3B | -$4.8B | -$2.3B | -$2.3B | -$667M | |
Repurchase of Common Stock | -- | -$628M | -$669M | -$898M | -$14M | |
Other Financing Activities | -$69M | -$441M | -$23M | -$56M | -$3M | |
Cash From Financing | -$5.5B | -$1.8B | -$1.5B | -$1.5B | -$317M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$687M | -$377M | -$727M | -$617M | $569M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$391M | $952M | $960M | $954M | $822M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $282M | $103M | $42M | $25M | -- | |
Depreciation & Amoritzation | $427M | $398M | $351M | $333M | -- | |
Stock-Based Compensation | $25M | $28M | $23M | $23M | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$29M | $163M | $127M | $238M | -- | |
Capital Expenditures | $220M | $118M | $140M | $155M | -- | |
Cash Acquisitions | $513M | -$36M | -$7M | -- | -- | |
Cash From Investing | $311M | -$192M | -$199M | -$188M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $235M | $292M | $546M | $323M | -- | |
Long-Term Debt Repaid | -$1B | -$398M | -$436M | -$263M | -- | |
Repurchase of Common Stock | -$48M | -$272M | -$285M | -$2M | -- | |
Other Financing Activities | -$22M | -$17M | -$35M | -$17M | -- | |
Cash From Financing | -$866M | -$394M | -$210M | $41M | -- | |
Beginning Cash (CF) | $3B | $2.7B | $1.9B | $1.2B | -- | |
Foreign Exchange Rate Adjustment | $13M | -$50M | -- | $2M | -- | |
Additions / Reductions | -$584M | -$423M | -$282M | $91M | -- | |
Ending Cash (CF) | $2.5B | $2.2B | $1.6B | $1.3B | -- | |
Levered Free Cash Flow | -$249M | $45M | -$13M | $83M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.